Citigroup’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
109,420
-110,776
| -50% | -$1.88M | ﹤0.01% | 2092 |
|
|
2025
Q1 | $4.3M | Buy |
220,196
+65,470
| +42% | +$1.28M | ﹤0.01% | 1515 |
|
|
2024
Q4 | $3.84M | Buy |
154,726
+47,342
| +44% | +$1.17M | ﹤0.01% | 1634 |
|
|
2024
Q3 | $2.63M | Buy |
107,384
+17,049
| +19% | +$418K | ﹤0.01% | 1833 |
|
|
2024
Q2 | $2.12M | Sell |
90,335
-168,851
| -65% | -$3.96M | ﹤0.01% | 1725 |
|
|
2024
Q1 | $8.56M | Buy |
259,186
+71,598
| +38% | +$2.37M | 0.01% | 960 |
|
|
2023
Q4 | $5.11M | Sell |
187,588
-10,009
| -5% | -$272K | ﹤0.01% | 1120 |
|
|
2023
Q3 | $4.75M | Buy |
197,597
+34,943
| +21% | +$840K | ﹤0.01% | 1062 |
|
|
2023
Q2 | $5.19M | Sell |
162,654
-56,847
| -26% | -$1.82M | ﹤0.01% | 1072 |
|
|
2023
Q1 | $6.72M | Buy |
219,501
+102,451
| +88% | +$3.14M | ﹤0.01% | 990 |
|
|
2022
Q4 | $4.58M | Sell |
117,050
-18,114
| -13% | -$708K | ﹤0.01% | 1097 |
|
|
2022
Q3 | $6.44M | Sell |
135,164
-19,104
| -12% | -$910K | ﹤0.01% | 991 |
|
|
2022
Q2 | $5.97M | Buy |
154,268
+103,543
| +204% | +$4.01M | ﹤0.01% | 1046 |
|
|
2022
Q1 | $2.91M | Sell |
50,725
-36,578
| -42% | -$2.1M | ﹤0.01% | 1500 |
|
|
2021
Q4 | $6.96M | Buy |
87,303
+46,989
| +117% | +$3.74M | ﹤0.01% | 1105 |
|
|
2021
Q3 | $3.51M | Sell |
40,314
-19,091
| -32% | -$1.66M | ﹤0.01% | 1493 |
|
|
2021
Q2 | $7.65M | Buy |
59,405
+13,440
| +29% | +$1.73M | ﹤0.01% | 1180 |
|
|
2021
Q1 | $3.68M | Buy |
45,965
+33,935
| +282% | +$2.72M | ﹤0.01% | 1548 |
|
|
2020
Q4 | $982K | Buy |
12,030
+9,924
| +471% | +$810K | ﹤0.01% | 2185 |
|
|
2020
Q3 | $52K | Sell |
2,106
-1,852
| -47% | -$45.7K | ﹤0.01% | 3466 |
|
|
2020
Q2 | $111K | Buy |
3,958
+439
| +12% | +$12.3K | ﹤0.01% | 3398 |
|
|
2020
Q1 | $63K | Buy |
+3,519
| New | +$63K | ﹤0.01% | 3603 |
|